Navigation Links
Helix BioPharma reports Q2 2008 highlights, financial results
Date:3/10/2008

AURORA, ON, March 10 /PRNewswire-FirstCall/ - Helix BioPharma Corp. (TSX, FSE: "HBP") today reported its highlights and financial results for the three and six months ended January 31, 2008.

HIGHLIGHTS

The Company's highlights for the quarter included:

- The signing of an agreement with KBI BioPharma for the development of

a clinical packaging format for L-DOS47, Helix's therapeutic

candidate for lung adenocarcinoma;

- The strengthening of the Company's cash position with the completion

of a CDN$16.9 million private placement of common shares on

December 19, 2007; and

- A shareholder vote in favor of management at the annual general

meeting on January 29, 2008.

"We have a solid base on which we can continue the advancement of our lead clinical compounds," said John Docherty, President of Helix BioPharma. "Recent developments include our receipt of positive Phase II data for our Topical Interferon Alpha-2b, the preparation of a format of L-DOS47 that is suitable for clinical testing, and the strengthening of our balance sheet. We are currently developing plans for Topical Interferon in an expanded patient population and we are anticipating L-DOS47 entering the clinic in a Phase I study."

RESULTS FROM OPERATIONS

Three and six months ended January 31, 2008, compared to same periods in

previous year

Total revenue was negatively impacted by lower sales of Orthovisc(R) in Canada for both the three and six month periods ended January 31, 2008. Overall expenditures were lower in the second quarter ended January 31, 2008 and is mainly attributable to higher costs in the same period a year ago, associated with the Company's annual shareholder meeting. On a year-to-date basis, overall expenditures were marginally lower, with the one-time charge in the first quarter of fiscal 2008 related to the resignation of the Company's Chairman bei
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Custom Learning Designs, ... eLearning solution using Tin Can API combined with ... CLD is a leading developer of training content ... companies worldwide. , Tin Can API is ... learners and trainers more accurately measure the Return ...
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
(Date:5/21/2013)... FL (PRWEB) May 21, 2013 Many ... breakouts as contributor to acne. Recently physicians from ... of mental stress on the skin, and suggested using ... help reduce the chemicals produced from stress that cause ... from the negative feelings acne brings about, stress causes ...
(Date:5/21/2013)... Bed bugs have become so widespread in ... many turn to chemical-based pesticides for help to completely get ... risks those solutions present, the company advised the public to ... , According to My Cleaning Products, chemical-based pesticides are ... be. It shared that the pests have already developed immunity ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3
... Campbell Alliance, the,leading management consulting firm specializing in ... Managed Markets Practice will,take a leadership role at ... Modeling Strategies hosted by the Center for Business,Intelligence ... 10 through 11 at,the Doubletree Hotel in Philadelphia, ...
... Biology 2008 Meeting, SAN DIEGO, April 3, ... Biothera, reduced the incidence of fever,and eliminated the ... school due to,the cold-like symptoms, researchers reported today ... Cox, Ph.D., Vice President of Research & Development ...
... by over ... 100%, year-over-year, ... ), manufacturer and marketer of state-of-the-art cardiac,surgery products and services, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), The Company currently expects ...
Cached Biology Technology:Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies 2Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies 3Wellmune WGP(R) Supplementation Alleviates Duration, Severity and 'Down Time' Due to Cold Symptoms 2Wellmune WGP(R) Supplementation Alleviates Duration, Severity and 'Down Time' Due to Cold Symptoms 3ATS Medical Expects First Quarter Revenue of $14.6 to $14.8 Million 2ATS Medical Expects First Quarter Revenue of $14.6 to $14.8 Million 3
(Date:5/20/2013)... University of Minnesota Medical School researchers from the ... the University,s Brain Tumor Program, have developed a new ... that allow them to discover new genes and gene ... was published this week in the journal Nature ... researchers in the lab of David Largaespada, Ph.D., professor ...
(Date:5/20/2013)... DIEGO (May 20, 2013) - A novel ... headline the groundbreaking research that will be unveiled at ... Conference (NBC). The meeting takes place Monday, May 20 ... Hotel and Marina. , "The main goal of ... fight against a pathogen that causes the disease", explained ...
(Date:5/19/2013)... Davis have engineered a strain of photosynthetic cyanobacteria to ... their findings today at the 113th General Meeting of ... we used synthetic biology approaches to probe and rewire ... for growth) cyanobacterial metabolism for the ability to grow ... on the study. He is part of Shota ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2Germ-fighting vaccine system makes great strides in delivery 2
... Market, Stantum,s SMK Series Will Let Vendors, ... SAN DIEGO, Sept. 23 Stantum Technologies,( ... today introduced a demo, evaluation and development board ... lets,users simultaneously move an unlimited number of fingers, ...
... 2008 A new study finds that environmental restoration ... study, published in Restoration Ecology, maintains that ... practice, more research should be done on whole ecosystems ... taking advantage of large restoration sites by conducting large-scale ...
... aromatase inhibitors to treat breast cancer or prevent its ... dietary supplement, researchers report. Genistein, a soy isoflavone ... can negate the effectiveness of aromatase inhibitors, which are ... promote tumor growth in some types of breast cancer. ...
Cached Biology News:Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology 2Lack of large-scale experiments slows progress of environmental restoration 2The dietary supplement genistein can undermine breast cancer treatment 2The dietary supplement genistein can undermine breast cancer treatment 3
The LAS-3000 imaging system combines new CCD camera technology with a simplified user interface to provide significantly improved system sensitivity with a wide range of modularities. This system is...
This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
This pump accomodates StemSep ; pump feed columns of the following sizes : 0.3in., 0.5in., 0.6in., and 1.0in.....
... kit provides complete components including positive and ... DNA fragmentation in cultured cells and tissue ... of apoptotic cells. Internucleosomal DNA ... mammalian cells. MBLs ApoDIRECT In Situ DNA ...
Biology Products: